Pooled Efficacy Results From Two Multinational Randomized Controlled Clinical Trials of a Single Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase®) for the Management of Vitreous Hemorrhage
- 31 October 2005
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 140 (4) , 573-584
- https://doi.org/10.1016/j.ajo.2005.04.018
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prevalence and risk indicators of visual impairment and blindness in Latinos*1the Los Angeles Latino Eye StudyOphthalmology, 2004
- The impact of visual impairment on self-reported visual functioning in Latinos*1The Los Angeles Latino Eye StudyOphthalmology, 2004
- Higher risk of multiple falls among elderly women who lose visual acuityOphthalmology, 2004
- Quality of life associated with visual lossOphthalmology, 2003
- Eales Disease—An UpdateSurvey of Ophthalmology, 2002
- The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathyCurrent Opinion in Opthalmology, 2001
- Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusionOphthalmology, 2001
- Anticipation for enzymatic vitreolysisBritish Journal of Ophthalmology, 2001
- VITRECTOMY FOR NONDIABETIC VITREOUS HEMORRHAGERetina, 1988
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983